🔗 Share this article Social Media Content Creators Fueling Parallel Trade for Unapproved Slimming Medication An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings. Experimental Treatment Acquiring Traction Online The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also obtaining promotional offers. Thriving Trade on Social Networks Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases. Understanding The Experimental Drug Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic. Medical Professionals Express Concerns However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of uncertain source. Some experts said the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro. Legal Status and Enforcement Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations. Several influencers try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison. Platform Response and Content Elimination According to the social media company, the platform has taken down problematic material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies. Online Trading Operations Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at home. Within minutes of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience. Product Information and Costs Within these communities, posts show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.” Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”. Service Oversight and Security Measures A spokesperson for Telegram said it actively monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Warnings “People are injecting substances they can’t verify. Even if the science behind retatrutide is sound, these online products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said. Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.” Producer Position A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.